PedAM
Pediatric Disease Annotations & Medicines
| Disease | graft-vs-host disease |
| Phenotype | C0026946|fungal infection |
| Sentences | 5 |
| PubMedID- 21200413 | The patient's posttransplant course was complicated by hepatic fungal infections, gvhd, involving the upper gastrointestinal tract and liver, and renal insufficiency resulting in a very slow but physically remarkable recovery to eventually include triathlon training. |
| PubMedID- 22215361 | Purpose: the results of a pharmacoeconomic study of the cost-effectiveness of posaconazole versus fluconazole in preventing invasive fungal infections (ifis) in patients with graft-versus-host disease (gvhd) are reported. |
| PubMedID- 21694893 | Another international study by ullmann et al in 2007 looked at prophylaxis against invasive fungal infections in patients with graft-versus-host disease (gvhd) on immunosuppressive treatment and compared posaconazole with fluconazole.24 this was a randomized, double-blind trial including patients who received an allogeneic hematopoietic stem cell transplant and developed gvhd. |
| PubMedID- 19802030 | Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with gvhd following haematopoietic sct. |
| PubMedID- 21716917 | A recent large-scale study reported that an average of 112-day prophylactic posaconazole therapy effectively prevented invasive fungal infection in patients with gvhd [94]. |
Page: 1